^
BIOMARKER:
MSI-H/dMMR + TMB-H
i
Other names: MSI | Microsatellite instability, TMB | Tumor Mutational Burden
Related biomarkers:
›
MSI-H/dMMR + TMB-H
|
CRC
|
MSI-H/dMMR + TMB-H
|
CRC
|
Immunotherapy Sensitive: C3 – Early Trials
|
Immunotherapy Sensitive: C3 – Early Trials
|
MSI-H/dMMR + TMB-H
|
Prostate Cancer
|
MSI-H/dMMR + TMB-H
|
Prostate Cancer
|
avelumab Sensitive: C4 – Case Studies
|
avelumab Sensitive: C4 – Case Studies
|
MSI-H/dMMR + TMB-H
|
HER2 Positive Breast Cancer
|
MSI-H/dMMR + TMB-H
|
HER2 Positive Breast Cancer
|
pembrolizumab + trastuzumab Sensitive: C4 – Case Studies
|
pembrolizumab + trastuzumab Sensitive: C4 – Case Studies
|
MSI-H/dMMR + TMB-H
|
Gastric Cancer
|
MSI-H/dMMR + TMB-H
|
Gastric Cancer
|
olaparib Sensitive: D – Preclinical
|
olaparib Sensitive: D – Preclinical
|
